FFAR4 and metabolic dysfunction-associated steatotic liver disease: Therefore, this study evaluated the effects in vivo of endogenous fatty acids on the improvement of NAFLD through the gut–liver axis, and the results were compared between WT mice and FFAR4-deficient mice.